Conditions: Restless Legs Syndrome (RLS)
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 45
Healthy volunteers: no

Brief summary:
The purpose of this study was to evaluate the safety of 2 dosage regimens of Intravenous (IV) iron Ferric Carboxymaltose (FCM) in comparison to placebo in patients with Restless Legs Syndrome (RLS)

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Ferric Carboxymaltose (FCM) intervention 2: Placebo
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: